Mayur Ian Somaiya New Amsterdam Pharma CO N.V. (NAMS) insider trading activity

Shares Held (Direct Ownership) 58.4K

53.64% 3M change

53.64% 12M change

Total Value Held N/A

Mayur Ian Somaiya Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 07 2026	BUY Grant, award, or other acquisition	-	25,500 Added 30.4%	58,382 Ordinary Shares
Jan 05 2026	SELL Open market or private sale	$170,173 $33.25 p/Share	5,118 Reduced 13.47%	32,882 Ordinary Shares
Jan 28 2025	SELL Open market or private sale	-	14,900 Reduced 28.17%	38,000 Ordinary Shares
Jan 28 2025	BUY Exercise of conversion of derivative security	$137,974 $9.26 p/Share	14,900 Added 21.98%	52,900 Ordinary Shares
Jan 27 2025	SELL Open market or private sale	-	46,983 Reduced 55.29%	38,000 Ordinary Shares
Jan 27 2025	BUY Exercise of conversion of derivative security	$435,062 $9.26 p/Share	46,983 Added 35.6%	84,983 Ordinary Shares
Jan 07 2025	BUY Grant, award, or other acquisition	-	38,000 Added 50.0%	38,000 Ordinary Shares

TCRR

TCR2 THERAPEUTICS INC. Healthcare

Chief Financial Officer

MIS

Chief Financial Officer

Cambridge, MA

Receive a notification when an Institution or Guru buys or sells NAMS shares.

Notify only if

Value

Get notified when an New Amsterdam Pharma CO N.V. insider buys or sells NAMS shares.

Notify only if

Operation

Value

Type

Receive news related to NewAmsterdam Pharma Co N.V.